Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with ima (Q43055133)
Jump to navigation
Jump to search
scientific article published on 25 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with ima |
scientific article published on 25 May 2010 |
Statements
1 reference
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with ima (English)
1 reference
Robert Chunhua Zhao
1 reference
Baijun Fang
1 reference
Ning Li
1 reference
Yongping Song
1 reference
Qin Han
1 reference
25 May 2010
1 reference
1 reference
89
1 reference
11
1 reference
1099-1105
1 reference
Identifiers
1 reference
1 reference